Stephens Investment Management Group LLC Cuts Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Stephens Investment Management Group LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,249,082 shares of the company's stock after selling 38,967 shares during the quarter. HealthEquity makes up approximately 1.4% of Stephens Investment Management Group LLC's portfolio, making the stock its 13th biggest position. Stephens Investment Management Group LLC owned 1.43% of HealthEquity worth $102,237,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HQY. State of Michigan Retirement System raised its position in HealthEquity by 2.4% during the 1st quarter. State of Michigan Retirement System now owns 21,022 shares of the company's stock worth $1,716,000 after purchasing an additional 500 shares during the last quarter. Norden Group LLC bought a new position in HealthEquity during the 1st quarter worth $391,000. Retirement Systems of Alabama raised its position in HealthEquity by 0.5% during the 1st quarter. Retirement Systems of Alabama now owns 107,744 shares of the company's stock worth $8,795,000 after purchasing an additional 501 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in HealthEquity by 9.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 150,801 shares of the company's stock worth $12,310,000 after purchasing an additional 13,224 shares during the last quarter. Finally, Peterson Wealth Services bought a new position in shares of HealthEquity in the 1st quarter worth about $671,000. 99.55% of the stock is owned by institutional investors.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the business's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the sale, the director now owns 4,823 shares of the company's stock, valued at $387,093.98. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the company's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. JMP Securities reissued a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reissued an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Finally, Bank of America decreased their target price on HealthEquity from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $103.83.

HealthEquity Stock Performance

Shares of NASDAQ:HQY traded up $1.08 during mid-day trading on Friday, reaching $86.33. The company had a trading volume of 555,503 shares, compared to its average volume of 606,029. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market cap of $7.54 billion, a price-to-earnings ratio of 71.37, a PEG ratio of 1.35 and a beta of 0.52. The company's 50-day moving average price is $81.24 and its 200-day moving average price is $79.92. HealthEquity, Inc. has a one year low of $61.81 and a one year high of $89.23.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.